Sunday, 19 April 2026

I think this should be done" A bridge course for connecting Pharm D and MBBS". (SARCASM) Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual?

I think this should be done : " A bridge course for connecting Pharm D and MBBS". This shall allow to produce talents and experts who have amalgamated, comprehensive  knowledge of  all the 3 most important aspects of healthcare which are medicine( for diagnosis of disease), pharmacy( for authentic knowledge of medications for prescription writing) and surgery (of course for operations). This has to definitely improve  and enhance quality of patient-care manyfolds . Why we shall always follow USA or western setups of education and service systems? They are good no doubt, as they are rich countries with large budgets for healthcare; but sometimes we must take initiatives and become leaders and provide path-breaking or a new-path setting grounds for others to follow.
Therefore I wrote a mail to secretory of MCI (secretary@mciindia.org), requesting for the same. It goes as follows:

Respected Sir/Madam,
I am currently pursuing 2nd year of PharmD (Post baccalaureate), which is a relatively a new curriculum started by PCI since 2008 and which is clinically oriented pharmacy. Up till now pharmacy in India was industry oriented i.e. pharmacist was more into manufacturing,sales,research of discovery of novel molecules and invention of formulations etc.But now with the advent of PharmD, it has become clinically oriented i.e. now a pharmacist is given an opportunity, allowed and equipped to play a role in direct patient care, giving pharmaceutical care. 
Madam, PharmD syllabus framed by PCI contains many pharmacy related subjects along with the subjects which are present in common in both MBBS and PharmD curriculum, i.e. subjects like anatomy and physiology (a lot lesser of it is there in PharmD), Pathophysiology, Biochemistry, Microbiology, Pharmacology, Biopharmaceutics (a lot more of it is there in PharmD)
Madam, I have a great respect for MBBS course and for physicians and surgeons. And I am currently 29 year old man. This is to ask you whether its feasible/ possible that a new course/curriculum may be framed and started by MCI within two to three years, which can bridge this gap between PharmD and MBBS.That is, a bridge-course(of 3years duration) which shall allow a PharmD graduate to be certified as MBBS,upon successfully completion of such a course. This may bring a new input, perspective and vision in patient care, to MBBS/physician as well as provide an opportunity, encourage, help fulfil dreams and strong aspirations of human beings like me, who wish to study such a curriculum, get a medical license, be a physician and earnestly want to play that very role in the healthcare system, at this stage and age of our lives.  
May all this come into effect for the 2014-2015 session.
Hoping for an encouraging, enlightening and positive reply on this request from you.
Yours truly,
Samrat Paul
Pharmacist A HealthCare professional? If so why pharmacy course is not?.
Has the Pharmacy education been got included in National Health Education Manual?

Yes, Pharmacy is included in the national health education framework in India, particularly through the initiatives of the Pharmacy Council of India (PCI) and its alignment with national health policies.
Key details regarding the inclusion of pharmacy in national health education include:
  • Revised Curriculum: The Bachelor of Pharmacy (B. Pharm) and Diploma in Pharmacy (D. Pharm) curricula are aligned with the National Education Policy (NEP) 2020, focusing on integrating pharmaceutical sciences with healthcare demands.
  • Public Health Roles: Pharmacists are recognized for their role in National Health Programs (NHPs) such as HIV/AIDS awareness, tobacco control, and tuberculosis control (RNTCP).
  • Competency-Based Training: The Education Regulations 2020 for the D. Pharm course (approved by the PCI) focus on professional training, and the PCI has implemented an Exit Examination to ensure standard quality among graduates.
  • Patient Counseling: The curriculum emphasizes "Health Education and Community Pharmacy," aiming to educate students on public health, patient counseling, and medication safety.
In addition, pharmacists are considered vital members of the healthcare team, and their role is increasingly recognized within the Indian Public Health Standards (IPHS) for health facilities. 


When pharmacy is included in national health education manual ?
Key developments in the inclusion and evolution of pharmacy in national education include:
  • 1948 (Pharmacy Act): Established to regulate the profession and education, creating the Pharmacy Council of India (PCI).
  • Pharm.D. Regulations 2008: Introduced a six-year Pharm.D. program to integrate clinical pharmacy into healthcare.
  • Education Regulation 2020: Updated the diploma course curriculum (ER-2020) and mandated specific staff-to-student ratios for B.Pharm and D.Pharm courses.
  • NEP 2020 Alignment: The Bachelor of Pharmacy (B.Pharm) curriculum is currently designed in alignment with the National Education Policy (NEP) 2020 to focus on outcomes-based education.
Social Pharmacy was notably introduced into the D.Pharm Part-I syllabus, aligning pharmacy education with public health needs. 

Saturday, 18 April 2026

Bariatric Surgery

Weight loss (bariatric) surgery, such as gastric sleeve, gastric bypass, or banding, helps individuals with severe obesity (typically BMI 
 or 
) lose weight by restricting food intake or reducing nutrient absorption. These procedures frequently resolve obesity-related conditions like type 2 diabetes and hypertension.
Common Types of Weight Loss Surgery
  • Sleeve Gastrectomy (Gastric Sleeve): Removes a large portion of the stomach, leaving a banana-shaped sleeve that restricts food intake.
  • Gastric Bypass (Roux-en-Y): Creates a small stomach pouch and connects it directly to the small intestine, bypassing part of the stomach and small intestine to reduce both intake and calorie absorption.
  • Adjustable Gastric Band: A ring with an inflatable band is placed around the top of the stomach to limit food intake.
  • Biliopancreatic Diversion with Duodenal Switch: A complex procedure combining, a smaller stomach pouch with a substantial reduction in nutrient absorption.
Eligibility Criteria
  • BMI of 40 or higher, or a BMI of 35-39.9 with serious obesity-related comorbidities (e.g., diabetes, sleep apnea).
  • Some guidelines suggest a BMI of 27.5-32.5+ for the Asian Indian population with comorbidities.
  • Recommended when other weight-loss methods like diet, exercise, or medication have failed.
Benefits and Results
  • Significant Weight Loss: Patients often experience significant and sustained weight loss.
  • Health Improvement: High rates of improvement or reversal of type 2 diabetes, high blood pressure, and sleep apnea.
  • Enhanced Metabolism: Many procedures alter hormone levels to decrease hunger and increase fullness.
Risks and Considerations
  • Requires lifelong dietary changes and nutritional supplements to prevent deficiencies.
  • Risks can include bleeding, infection, blood clots, or long-term issues like dumping syndrome or hernia.
  • Requires comprehensive pre-operative evaluation and long-term follow-up care.
Procedure Techniques
Most surgeries are performed using minimally invasive techniques, such as laparoscopy (small incisions, camera) or robotics, which offer quicker recovery times

Government of india, Ministry of AYUSH

The Ministry of Ayush was formed on the 9th of November 2014 with a vision of reviving the profound knowledge of our ancient systems of medicine and ensuring the optimal development and propagation of the Ayush systems of healthcare. Earlier, the Department of Indian System of Medicine and Homoeopathy (ISM&H) formed in 1995, was responsible for the development of these systems. It was then renamed as the Department of Ayurveda, Yoga, and Naturopathy, Unani, Siddha and Homoeopathy (Ayush) in November 2003 with focused attention towards education and research in Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homoeopathy.

BHMS

BHMS stands for Bachelor of Homeopathic Medicine and Surgery, a 5.5-year undergraduate degree in India focused on alternative, holistic medicine. It trains students to diagnose and treat patients using natural healing methods, including a 4.5-year academic study and a 1-year compulsory internship.
Key Details About BHMS:
  • Course Structure: The curriculum covers Anatomy, Physiology, Pharmacy, Materia Medica, and Organon of Medicine
    .
  • Eligibility: Students typically need a 10+2 qualification with Physics, Chemistry, and Biology, along with passing the NEET entrance exam.
  • Duration: 5.5 years, including 4.5 years of academic study and 1 year of internship.
  • Career Opportunities: Graduates become licensed homeopathic doctors capable of working in private clinics, government hospitals, or pursuing higher education.
BHMS is distinct from MBBS, as it specializes in homeopathic principles rather than allopathic medicine. 



BHMS CCH refers to the Central Council of Homoeopathy (CCH), the former statutory regulatory body in India that governed homeopathy education and practice under the Ministry of AYUSH. It was responsible for regulating the Bachelor of Homeopathic Medicine and Surgery (BHMS) degree course. Note that the CCH has been replaced by the National Commission for Homoeopathy (NCH).
Key Details Regarding CCH and BHMS:
  • Role: The CCH (now NCH) regulates BHMS education, ensuring standards in admission, curriculum, and examinations.
  • BHMS: Bachelor of Homeopathic Medicine and Surgery, a 5.5-year undergraduate degree.
  • Context: While CCH primarily means the regulatory council, BHMS graduates may also pursue a "Certificate in Community Health" (CCH/Bridge Course) to work in health centers.
Synonyms/Related Terms:
  • NCH (National Commission for Homoeopathy): The new governing body replacing CCH.
  • Council of Homoeopathy: Frequently used to refer to the central governing body.

BAMS

BAMS (Bachelor of Ayurvedic Medicine and Surgery) is a 5.5-year undergraduate degree in India integrating traditional Ayurveda with modern medicine. It covers subjects like anatomy, physiology, and herbal medicine, requiring a NEET-qualified 12th-grade pass (PCB). Graduates work as registered Ayurvedic doctors.
Key Details About BAMS:
  • Duration: 5.5 years (4.5 years academic study + 1-year mandatory internship)
    .
  • Full Form: Bachelor of Ayurvedic Medicine and Surgery.
  • Admission Process: Admission is based on the NEET-UG exam.
  • Curriculum: Studies cover Rachana Sharir (Anatomy), Kriya Sharir (Physiology), Ayurveda Samhita (Classical texts), Dravyaguna (Pharmacology), and modern medical subjects.
  • Career Scope: Graduates can work as Ayurvedic doctors, Medical Officers, Panchakarma Specialists, or in research/pharmaceuticals.
  • Salary: Starting salaries typically range from INR 3 LPA to INR 15 LPA.
  • Further Studies: Graduates can pursue PG courses like MD (Ayurveda) or MS (Ayurveda).
The program is regulated by the National Commission for Indian System of Medicine (NCISM). 

Thursday, 2 April 2026

Approved Drug Products with Therapeutic Equivalence Evaluations( Orange Book)

Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, is a publication produced by the United States Food and Drug Administration (FDA), as required by the Drug Price and Competition Act (Hatch-Waxman Act).

The Hatch-Waxman Act was created to '"strike a balance between two competing policy interests:

  1. inducing pioneering research and development of new drugs and
  2. enabling competitors to bring low-cost, generic copies of those drugs to market'".[1]

The Orange Book identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act. The publication does not include drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation [DESI] review [e.g., Donnatal Tablets and Librax Capsules] or pre-1938 drugs [e.g., Phenobarbital Tablets]). The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Inclusion of products on the List is independent of any current regulatory action through administrative or judicial means against a drug product.

In addition, the Orange Book contains therapeutic equivalence evaluations (2 character rating codes) for approved multisource prescription drug products (generic drugs). These evaluations have been prepared to serve as public information and advice to state health agencies, prescribers, and pharmacists to promote public education in the area of drug product selection and to foster containment of health care costs.[2] Therapeutic equivalence evaluations in this publication are not official FDA actions affecting the legal status of products under the Act.

Finally, the Orange Book lists patents that are purported to protect each drug. Patent listings and use codes are provided by the drug application owner, and the FDA is obliged to list them. In order for a generic drug manufacturer to win approval of a drug under the Hatch-Waxman Act, the generic manufacturer must certify that they will not launch their generic until after the expiration of the Orange Book-listed patent, or that the patent is invalid, unenforceable, or that the generic product will not infringe the listed patent.

The Orange Book does not list biological products such as vaccines. These are listed in later-enacted Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations, commonly known as the Purple Book.[3]

The DrugPatentWatch website offers a "Free DrugPatentWatch Orange Book PDF Library" from which the public can download digital copies of every FDA Orange Book, from the 1st Edition in 1980 to the most recent (as of 2020)

Friday, 20 March 2026

PHARM D

Doctor of Pharmacy (Pharm.D.New Latin Pharmaciae Doctor) is a professional doctorate in pharmacy. In some countries, it is a first professional degree, and a prerequisite for licensing to practice the profession of pharmacy or to become a Clinical pharmacist. In many countries they are allowed to practice independently and can prescribe the brand of drugs directly to the patients. Pharm.D program has significant experiential or clinical education components in introductory and advanced levels for the safe and effective use of drugs. Experiential education prepares graduates to be practice-ready as they already spent a significant amount of time training in areas of direct patient care and research. A Pharm D graduate can also use the prefix 'Dr' along with their name. [1]

Africa[edit]

Algeria[edit]

In Algeria, Doctor of Pharmacy degree replaced the state's diploma of pharmacist in 2011, thus concepts on clinical pharmacy and pharmaceutical care were taught for the first time.

Egypt[edit]

Pharm.D is a postgraduate professional degree offered by many faculties of pharmacy in Egypt. It is a professional degree after earning a B.sc in pharmaceutical science. The duration of the program consists of two calendar years. The first year consists of many didactic and pharmacotherapy, pharmacokinetics, pharmaceutical care of many diseases. The second year consists of rotations in hospitals in many specialties from the universities that offer this degree, such as faculty of pharmacy Cairo University, faculty of pharmacy Ain Shams University, faculty of pharmacy Alexandria University.

Ghana[edit]

Pharm.D is a 6-year course offered in Ghana from the academic year 2012/2013, initially by the Kwame Nkrumah University of Science and Technology (KNUST). It leads to the award of the Doctor of Pharmacy certificate making one eligible to qualify, register and operate as a licensed pharmacist. An aggregate of 06 in the WASSCE results is currently the acceptable cutoff point. Also, a year Top-up program was rolled out in the 2017/18 academic year for practicing pharmacists with the Bpharm qualification to obtain the Pharm.D qualification which will soon become the minimum degree for licensure. The University of Health and Allied Sciences (UHAS)-Volta Region (2016/17 academic year), The University of Ghana-Legon and Central University College-Miotso (both in 2018/19 academic year), have also rolled out the Pharm.D program.
The first graduating group of the Pharm.D course in Ghana graduated in 2018. Much is expected of them to change the practice of pharmacy in Ghana to be more patient-centered than drug-centered and they are anticipated in various hospitals all over the country.

Morocco[edit]

Pharm.D. is a program offered at the Faculty of Medicine and Pharmacy of Rabat.[2] and the Faculty of Medicine and Pharmacy of Casablanca.[3]

Nigeria[edit]

Presently, there are only two universities in Nigeria offering the Doctor of Pharmacy (Pharm-D.) program. These are the University of Benin, Benin City, Nigeria and Bayero University Kano Nigeria. The University of Benin commenced the program in 2001 following the approval given for the commencement of the program by the regulatory government agency for pharmacy education and practice in the country, Pharmacists Council of Nigeria (PCN). It was not until 2016 that the overall regulatory government agency for all university degree programs in the country, National Universities Commission (NUC), formally approved the Pharm-D degree program. The University of Benin PharmD is a six-year undergraduate program. On successful completion of the program, students are awarded both the Bachelor of Pharmacy (BPharm) degree and the Pharm-D. Prior to the commencement of the program, the university offered a five-year BPharm degree program which commenced in 1970. In the PharmD program, students are given extensive didactic preclinical/professional clinical preparation as well as clinical training (including pharmaceutical care) in different hospitals and community pharmacies.Student are prepared to have knowledge about patients counselling,Drug information, pharmaceutical care, ADR reporting, pharmacovigilance and much more. Pharmacy council of Nigeria and the national professional body of pharmacists, Pharmaceutical Society of Nigeria (PSN), have envisaged that in the near future, Pharm-D degree will become the minimum educational qualification for the registration/licensing of fresh graduates of Nigeria's pharmacy schools for practice in the country. Through the efforts of the PCN, most pharmacy schools in Nigeria are now intensifying their preparations to commence the Pharm-D degree program.

South Africa[edit]

Since 2006, Pharm.D is a post-graduate course being offered by Rhodes University.[4]

Tunisia[edit]

The Pharm.D program has been available in Tunisia since 1975.

Asia[edit]

[icon]
This section needs expansionYou can help by adding to it. (June 2008)

Bangladesh[edit]

At present a five-year professional degree is offered in various public universities in Bangladesh. Previously, it was a four-year degree (Graduation) and a one-year degree (Post-Graduation) in Pharmacy is offered in numerous universities of Bangladesh. The study material is taught in English. The textbooks, exams as well as thesis are also provided in English. The universities are the University of Dhaka since 1964, Jahangirnagar University since 1982, University of Chittagong, Rajshahi UniversityKhulna UniversityJagannath UniversityPabna University of Science & Technology, Jessore University of Science & Technology and Noakhali Science & Technology University. All of these are government universities. There are also 20 private universities in Bangladesh offering pharmacy education. Among them BGC Trust University Bangladesh (BGCTUB), Southeast University(SEU), East West UniversityNorthern University Bangladesh since 2003, Daffodil International University , University of Science and Technology Chittagong (USTC), Stamford University Bangladesh (SUB), Manarat International University (MIU), The University of Asia Pacific, International Islamic University ChittagongNorth South University, ASA University Bangladesh (ASAUB) and University of Development Alternative (UODA) are the top rated private universities. It is the best for home and abroad students. The B.Pharm is completed in 4 years and the M.Pharm in one year. Pharmacy Council of Bangladesh (PCB) is the Professional Regulatory Authority for Pharmacists in Bangladesh.

India[edit]

Not to be confused with DPharm.
Pharm.D course introduced by the Government of India and Pharmacy Council of India in 2008. The Pharm.D program is a pre-PhD, post-graduate professional doctorate of 6 years. It was introduced to improve clinical pharmacy services in India and it is the only pharmacy service which is in direct contact with patient health care system. The first batch of Pharm.D post baccalaureate students graduated in August 2011 and 1st regular batch graduated in June 2014. The Pharm.D degree requires five years of classroom and hospital based didactic study (two years didactic post-baccalaureate course), followed by one year of internship training in hospitals in addition to ongoing practicals and research project.[5]With reference to Clarification on Pharm.D qualification,[6] it is clarified to all universities that Pharm.D is a post graduate degree and passing students can directly register for Ph.D From 2012.

Nepal[edit]

Nepal started three years post baccalaureate Pharm.D in 2010 in Department of Pharmacy, Kathmandu University, Dhulikhel, Kavre. It is the first batch in Nepal pursuing the degree. The first batch is now currently involved in a 1 years internship at different well established teaching hospitals of Nepal. The students are enrolled in Manipal Teaching Hospital, Pokhara, College of Medical Sciences Bharatpur and KIST medical College, Lalitpur for their internship of 1 year. Kathmandu University has already enrolled the next two batches for further continuation of the Pharm D program.

Pakistan[edit]

Pharmacy Council of Pakistan (PCP) is the professional regulatory authority for Pharmacists in Pakistan.[7] Earlier (before 2003), pharmacy degree was a 4-year undergraduate B.Pharmacy (Bachelor of Pharmacy) that focused mainly on drug manufacturing and pharmaceutics but later in 2004, Higher Education Commission of Pakistan and Pharmacy Council of Pakistan collaboratively changed the syllabus and upgraded the B.Pharmacy degree to Pharm.D. Pharm.D (Doctor of Pharmacy) is a 5-year professional degree in Pakistan. Admission requirements for Pharm.D is 12-years of schooling or HSSC (Higher Secondary School Certificate) in pre-medical subjects (Biology, Chemistry and Physics etc.) or A-levels in similar subjects. Passing an aptitude test is mandatory for getting admission into Pharm.D program. As compared to B.Pharm, Pharm.D is a more clinical and research oriented program. Some pharmacy institutes have collaboration with hospitals for providing clinical clerkship during 4th & 5th Professional year. In 2008, first batch completed Pharm.D program.

Philippines[edit]

Centro Escolar University Makati offers the degree Doctor of Pharmacy (Pharm.D.). The degree requires the completion of 52 units of formal course work and 36 units of clinical rotation done at the Makati Medical Center and The Medical City. It is a 2-year postbaccalaureate degree open to licensed pharmacists in the Philippines.

Taiwan[edit]

In Taiwan, Doctor of Pharmacy (Pharm. D.) program was first introduced in National Taiwan University since Fall 2009.
Pharm. D. program in Taiwan is a six-year academic program, while Bachelor of Science in Pharmacy (BSc. Pharm.) is a four-year or five-year program. Students taking either Pharm. D. or BSc. Pharm. program are all eligible to take the pharmacist licensure exam. The universities offering Pharm. D. program or BSc. Pharm. program are listed below.
UniversityPharm. D.
(6-year program)
BSc. Pharm.
(4-year program)
BSc. Pharm.
(5-year program)
Notes
National Taiwan UniversityVStopped offering in fall 2014.Currently only Pharm. D. program is available.
National Yang-Ming UniversityVSince fall 2016.
Taipei Medical UniversityVVPharm. D. program is available since fall 2013. Currently both programs are available to students.
National Defense Medical CenterVStopped offering in fall 2015.Currently only Pharm. D. program is available.
National Cheng Kung UniversityVSince fall 2015.
China Medical UniversityVVStudents can select whether they want to join Pharm. D. program after admission.
Kaohsiung Medical UniversityStopped offering in fall 2019.V (since fall 2019)5-year program will start in fall 2019.
Chia Nan University of Pharmacy & ScienceStopped offering in fall 2018.V5-year program started in fall 2018.
Tajen UniversityVVPharm. D. program is available since fall 2016. Currently both programs are available to students.

Thailand[edit]

In Thailand, Doctor of Pharmacy (Pharmaceutical Care) program first curriculum in Asia was established at Faculty of Pharmaceutical Sciences, Naresuan University in 1992. The Pharm.D. Program (Pharmaceutical care or Industrial Pharmacy) is a six-year academic program.

Europe[edit]

Belgium[edit]

The education of pharmacists in Belgium requires a minimum of five years of university study. EU-harmonisation has led to division into three bachelor and two master years. A bachelor title is, however, not used at all professionally. Belgium considers the educational level of their current (M.Sc.) degree in pharmacy to be comparable to the Pharm.D. title used in the United States. To become a hospital pharmacist, a three-year residency program has to be completed after obtaining the M.Sc. in pharmaceutical sciences.

Czech Republic and Slovakia[edit]

In both countries, the PharmDr. (Pharmaciae doctor) diploma can be obtained by pharmacists who have previously graduated in pharmacy (Magister, Mgr.) (the undergraduate study of pharmacy takes five years). Applicants must defend a research or experimental thesis, and pass a rigorous examination. The PharmDr. title is highly prestigious and written in front of the name. It is different from the postgraduate Ph.D. degree.

France[edit]

In France, Pharm.D studies can only be accessed through a competitive examination ("concours", with numerus clausus) happening at the end of the first year of health studies. Most candidates hold a Scientific Baccalaureate from the equivalent to high schools (lycée). In case of failure, it is possible to retry once. Yearly success rate depends on the university's current numerus clausus and the number or registered students, ranging from 10 to 30% bearing in mind that second-time participants are three to four times more likely to succeed than students trying for the first time.
In order to obtain the state diploma of "Doctor of Pharmacy", the studies last a minimum of six years, or nine years for students choosing residency (hospital pharmacy or medical biology). It is accessible through another competitive exam, even more selective. It lasts four years and gives another diploma of specialist like in medicine (DES for "diplôme d'études spécialisées" ). Students must specialise when entering the 5th year, and choose between dispensing pharmacy, pharmaceutical industry or hospital residency. In any case, a 12-month part-time hospital externship is mandatory during the fifth year, although some flexibility is possible for students choosing industry.
Sixth year for industry is generally dedicated to further specialisation with a former Professional master's degree or a former Research master's degree including internship.
In France, since the harmonization of European Union in September 2005, the student who chooses the industry/research orientation have a six-month period of part-time hospital externship, and 3 to 6 months of full-time training in a pharmaceutical industry or a research lab.

Hungary[edit]

In Hungary, pharmacists obtain their master's degree, after five years of study. In the fifth year, students must undergo a professional training, that lasts for two+two months (autumn and spring) in a public pharmacy and one month in a hospital. At the end of this period, the student must pass a nationwide exam to be legally entitled for practicing the profession of pharmacy, after acquiring the pharmacist work license. According to the new law in 2008, which is valid from 2009, all pharmacists, who have acquired the master's degree of Pharmacy, are entitled to the Doctor of Pharmacy.

Italy[edit]

In order to obtain the state diploma of "Doctor of Pharmacy", the studies last a minimum of 5 years, or 9 years for students choosing residency (hospital pharmacymedical biology) or pharmacology. In Italy the Professional degree in Pharmacy lasts 5 years, which includes a 6-month professional training in a public pharmacy or hospital. At the end of this period, the student must pass a nationwide exam to be legally entitled to practise as a pharmacist. The subscription to "Pharmacist's Order", or in Italian "Ordine dei Farmacisti", is required for working in private and public pharmacies or hospitals. It is not required if the pharmacist is working at a pharmaceutical company. Besides the professional degree in Pharmacy, the title of Doctor of Pharmacy can be achieved in Italy by obtaining a MSc in Medicinal Chemistry and Pharmaceutical Technology (Chimica e Tecnologia Farmaceutiche, CTF) and then subscribing to the "Pharmacist's Order".

Malta[edit]

In Malta, the warrant to practice as a pharmacist is given after the Master of Pharmacy course is completed successfully. The University of Malta, however, offers a Level 8 Postgraduate Degree known as the Doctorate in Pharmacy (Pharm.D.) which expands the pharmacist's knowledge on clinical, pharmacoeconomic, and regulatory aspects. The Doctorate in Pharmacy course is offered in collaboration with the University of Illinois in Chicago and uses a mixed-approach learning programme including theory and practical experience.[8][9]

Netherlands[edit]

The education of pharmacists in the Netherlands requires a minimum of six years of university study. EU-harmonisation has led to division into three bachelor and three master years. A bachelor title is, however, not used at all professionally. The Dutch consider the educational level of their current (M.Sc.) degree in pharmacy to be comparable to the Pharm.D. title in use in the United States. Before the harmonization a four-year Master of Science was superseded by two more years of university education preparing for pharmacy practice. To become a hospital pharmacist, a four-year residency program has to be completed after that.

Portugal[edit]

In Portugal, pharmacy studies consists of four years of basic school, five years of preparatory school, and three years of high school, where afterward the student is submitted to nationwide exams. The process is the same for every degree the student chooses, from medicine to engineering. The student takes the master's degree in Pharmaceutical Sciences (equivalent to the PharmD program) in one of the nine Pharmacy faculties with their own respective numerous clausus which comprises a six-year rigorous study (5 with the uniformities in EU teaching). Finished the degree, the academic title of Doctor of Pharmacy is issued. The graduate can then enroll in the regulatory institution for the Pharmacist profession in Portugal called, "Portuguese Pharmaceutical Society" or, in Portuguese, "Ordem dos Farmacêuticos". After the enrollment, the title of Pharmacist is issued. Afterwards, Pharmacists can start their career in a limitless number of professional areas that range from community pharmacies, drug development, fundamental or applied research, biotechnology to areas such as forensic sciences, toxicology, regulatory affairs, clinical analysis, law enforcement (scientific police), bromatology, drug marketing, regulatory authorities, university teachers, etc. The Pharmacists can also choose to become a specialist in one of following areas of activity: Pharmaceutical Industry, Regulatory Affairs, Hospital Pharmacy, and Clinical Analysis. Each specialization requires an additional 5-year professional study program guided by a tutor in the respective area of knowledge. This training includes regular evaluations by the professional competent authority ("Ordem dos Farmacêuticos"), which also requires an exam at the end of the 5-year training. After the success at the exam, the Pharmacist then becomes a specialist in its area of expertise.

Spain[edit]

In Spain, Pharmacy studies can be accessed after completing five and a half years of university college (with at least 6 months of initiation to Pharmacy Practice). The Licenciado en Farmacia or Grado en Farmacia (equivalent to the Pharm.D. program) English degree is the only title that allows holders to practice the profession of Pharmacy in Spain. To become a Hospital Pharmacist a person with a degree in Pharmacy must enter a selection process (national selection process called FIR) to initiate a Pharmacy Residency period of professional training during 4 additional years (including one full year of advanced clinical practice in different medical wards). Apart from the professional degrees, like with any other university studies, Pharmacy degree allows holders to pursue an academic career by enrolling master's and doctorates programs (MSc and PhD) in several scientific fields (pharmaceutical technology, pharmacokinetics and biopharmaceutics, biomedical sciences, cosmetics & pharmaceutical industry, pharmaceutical and organic chemistry, physical chemistry, food sciences, pharmacology, toxicology, public health, etc.). Master's usually lasts 1–2 years and PhD no less than 4 years.
In summary, in Spain an entry-level pharmacy degree lasts 5 years and a Hospital Pharmacy Specialist needs 9.5 years of education and/or training. Hospital Pharmacy residents are paid during their residency period. There are other residencies available to pharmacists such as Medical Biology, Clinical Biochemistry, Immunology, Microbiology, Radiopharmacy, Pharmaceutical Analysis, and Industrial Pharmacy lasting from 2 to 4 years.
Pharmacists usually work as retail pharmacists (private practice), hospital pharmacists, primary care pharmacists, medical biologists, scientists (private and public biomedical research institutions), as university professors (Pharmacy, Medicine, Biology, Food Sciences, Biochemistry, Veterinary, Nursing, etc.), and as technicians and executive managers (pharmaceutical and biotechnology companies and governmental institutions).

Sweden[edit]

Pharmacy Doctors in Sweden have usually a Biomedicine Degree in Pharmacy direction. Biomedicine program is a 5-year education (3 years candidate + 2 years master) with a labor market in the pharmaceutical industry, biotechnology and healthcare. The biomedicine program with Pharmacy / Pharmacology direction offered by universities in Gothenburg, Umea and Uppsala in Sweden.
In Sweden, the pharmacist (Apotekare) are not presented as a pharmacy doctors. Pharmacists (Apotekare) have the largest labor market in pharmacies or hospital pharmacies and can also work closely with health care to improve drug (Clinical Pharmacy). For example, in pharmacy business may pharmacists also work with education and teaching.

Middle East[edit]

Iran[edit]

In 1930 Tehran University changed the Pharmacy degree from master's to doctorate, and the duration of the study was increased to 5 years. Graduates need to present and defend their theses in different fields of pharmacy, and this adds another year to their studies, and generally after 6 years students can graduate as Doctor in Pharmacy. The master's degree in Pharmacy was available in Tehran University since 1926.

Israel[edit]

In Israel the Pharm.D program is offered only by the Hebrew University of Jerusalem.[10] Unlike European countries, in order to practice community pharmacy in Israel, only a bachelor's degree is required.

Jordan[edit]

In Jordan, the Pharm.D. program is offered by the University of Jordan and Jordan University of Science and Technology at the undergraduate level. This program is not to be confused with the BSc. in Pharmacy program even though both programs are still offered today. Students complete 5 years of academical work and 1 year of clinical practice to earn the degree. This program is offered at public universities only: at the University of Jordan and Jordan University of Science and Technology. The University of Jordan calls this degree BSc. in Doctor of Pharmacy, which is granted after a successful completion of 216 credit hours.[11] The Jordan University of Science and Technology has a similar credit hour requirement and calls the degree the BSc. of Doctor of Pharmacy degree.[12]

Lebanon[edit]

Pharmacy degree is awarded by several Lebanese universities (upon a decree by the Lebanese government).

Palestine[edit]

At Al Najah, University of Palestine and Birzeit University[citation needed]

Qatar[edit]

In Qatar, pharmacy degrees are offered by the new College of Pharmacy at the Qatar University. Students were accepted into the 5-year BSc (Pharm) program commencing in 2007. Students will be accepted into the final year of the 6-year Pharm.D program in 2011. Accordingly, the first graduates of the Pharm.D program are expected in 2012. The program adopts a Canadian curriculum and received early accreditation by the Canadian Council for Accreditation of Pharmacy Programs (CCAPP) in February 2009. This is the first international program to undergo review and receive accreditation by this sole Canadian accreditation agency.

Saudi Arabia[edit]

Started in 2001 at King Abdulaziz University, then in 2005 at Ibn-Sina National College, then 2006 at KFU, then 2007 at Qassim University. In 2008, KSU College of Pharmacy at Riyadh, College of Pharmacy at Kharj, and Taif University. In 2009, Almaarefa College started their Pharm.D. program, and Shaqra University in 2011.
The degree duration in Saudi Arabia is six years in total, including one academic year of clinical rotations. According to the Saudi Commission for Health Specialties, if a student graduates with a (minimum six years) Pharm.D. degree, then the graduate has the chance to further develop himself. This can be achieved by taking an Accredited Residency Training Program that is at least one year long (for a total of seven years, minimum). Upon successfully completing both the Residency program and the Pharm.D., the graduate can apply for Professional Equivalent (only equivalent in practice) to the master's degree in Pharmacy.
The Pharm.D degree is now offered by almost all pharmacy colleges in Saudi Arabia. This is a transitional period as this degree will replace the conventional Bachelor of pharmacy degree in near future and the old bachelor's degree will be phased out.

United Arab Emirates[edit]

The Doctor of Pharmacy program started in 2008 by the College of Pharmacy, at Gulf Medical University, Ajman.

North America[edit]

Canada[edit]

Currently, in Canada, the BPharm (and not Pharm.D.) is the minimum qualification required to practice pharmacy. In Canada the Pharm.D. program is offered in both English and French, and as a first professional degree as well as a postgraduate degree. Students enrolled in the program must have graduated from a CCAPP (Canadian Council for Accreditation of Pharmacy Programs) or an ACPE (Accreditation Council for Pharmacy Education) school with an accredited teaching program or must have obtained a Certificate of Qualification from PEBC.
As of 2007, the Pharm.D. professional degree program in French is offered at the Université de Montréal and, as of 2011, at the Université Laval. The Université de Montréal was the first Canadian university to offer the Pharm.D. program as a first professional degree instead of the BPharm in pharmacy. In 2013, the University of Alberta would be offering a Pharm.D. as a post-professional degree, and a BPharm is required for admission into the program. The University of Toronto replaced their entry-level BPharm curriculum with an entry-to-practice Pharm.D. curriculum in 2011, with approval being granted[by whom?] in 2013.
The Pharm.D. degree is also offered as a postgraduate degree at the University of British Columbia and the University of Toronto. However, by the year 2020, most, if not all Canadian Pharmacy schools will have changed their Entry-To-Practice programs that awarded successful graduates with a Bachelor of Pharmaceutical Sciences to Entry-To-Practice Pharm.D. as the scope of practice for pharmacists continue to expand and change. Once this change is implemented, UBC will no longer have a separate 2-year Pharm.D. Program that is currently offered.
On January 23, 2013, the government of Ontario approved the University of Toronto and the University of Waterloo applications for the entry-to-practice Doctor of Pharmacy (Pharm.D.) program. Students graduating in 2015 will be the first cohort under this new undergraduate Pharm.D. program.
Dalhousie University (Halifax, Nova Scotia) is in progress of transitioning to the Pharm.D. program. Undergraduate applicants will require a minimum two years of prerequisite courses.
In the Fall of 2017, Memorial University of Newfoundland (St. John's, Newfoundland and Labrador), also replaced their BPharm program with the Pharm.D. program, with the first graduating class expected in 2022. This program requires one full year of prerequisite courses.

United States[edit]

In the United States, the Doctor of Pharmacy (Pharm.D.) is a professional degree that offers opportunities in research, teaching, clinical practice, industry, manufacturing, judicial, and a multitude of other areas.
After completing the required prerequisites or obtaining a transferable bachelor's degree, pharmacy school is another four years. In general, the total collegiate timeline to become an entry level pharmacist is six to eight years; three to four years undergraduate prerequisite work/bachelor's degree then three (accelerated track) to four years professional doctorate.
Acceptance to a Pharm.D. program is competitive. Along with excellent natural science grades, most schools require students to take a pharmacy college admissions test[13] (PCAT) and complete 90 credit hours of university coursework in the sciences, mathematics, composition, and humanities before entry into the Pharm.D. program. Due to the extensive admission requirements and highly competitive nature of the field, many pharmacy students complete a bachelor's degree before entry to pharmacy school. Some institutions still offer six-year accelerated Pharm.D. programs (similar to six-year MD programs).
Residency is an option that is typically one to two years in length. Graduating candidates typically apply their final year of the Pharm.D. program. The accrediting body for most residency positions is the American Society of Health-System Pharmacists. Applications are submitted through the Pharmacy Online Residency Centralized Application Service; which opens 3 November each residency year. Residency sites interview candidates and a ranking occurs prior to a match process. "The match" is facilitated via the National Matching Services Inc. in conjunction with Pharmacy Online Residency Centralized Application Service website portal. A residency is useful; especially for new graduates who do not yet have adequate patient care experience or potentially seeking accelerated and additional experiential training.
An ACPE Accredited doctorate of pharmacy (Pharm.D.) is currently the only degree accepted by the National Association of Boards of Pharmacy (NABP) to be eligible to "sit" for the North American Pharmacist Licensure Examination (NAPLEX). Previously, the United States had a five-year bachelor's degree in pharmacy. For pharmacy graduates holding the Bachelor of Science degrees currently licensed in the United States wishing to attain the Pharm.D., there are programs available to bridge that gap. These programs are fully accredited by Accreditation Council for Pharmacy Education (ACPE), but they are only available to current B.S.Pharm. graduates with a license to practice pharmacy in the United States.
The current Pharm.D. degree curriculum is considerably different from that of the prior B.S. in pharmacy. It now includes extensive didactic clinical preparation, hands-on clinical practice experience in a wider array of healthcare settings, and a greater emphasis on clinical pharmacy practice pertaining to pharmacotherapy optimization. Requirements in the US to becoming a pharmacist include graduating from a Doctor of Pharmacy from an ACPE accredited program, conducting a specified number of hours in internship under a licensed pharmacist (i.e. 1800 hours in some states), passing the NAPLEX, and passing a Multistate Pharmacy Jurisprudence Examination (MPJE).

South America[edit]

Brazil[edit]

In Brazil the title of pharmacist is awarded after completion of certified graduate studies; while the term Pharm.D. is not formally regulated it can be used and is commonly added to the graduate's professional license (issued by the regional pharmacy (Conselho Regional de Farmacia)).
Many universities award sub-titles or co-titles including Biochemist and Industrial Pharmacist. University of São Paulo and a few others have awarded specialization titles for many years for their Pharmacy and Biochemistry graduate students, including toxicological and clinical analysis, food and nutrition and industrial pharmacy, which are also equivalent to different degrees in the US and Europe.
Whereas Bachelor of Pharmacy takes a minimum of 4 years, the Pharmacist-Biochemist degree is completed by 4 and 1/2 years of full-time studies with at least 720 hours of internship. The student can opt to get the degree during evening and it takes 6 years with Saturday classes (full day) and also at least 720 hrs of internship.
Although many universities grant a degree of Doctor in Pharmaceutical Sciences or Doctor in Pharmacy after completion of original research dissertation, those are not professional but a post-graduate course and do not grant permission to work as a pharmacist.

Chile[edit]

In Chile, the title of Pharmacist (Quimico Farmaceutico) is granted after completing 10 or 11 semesters of full-time studies in an accredited University. The Pharmacist degree is a Professional Degree, awarded after finishing 5 years of study (Bachelor in Pharmacy), and then finish an internship of 6 months on the specialization area of the student (Pharmaceutical Lab, Community Pharmacy, Hospital Pharmacy).
The pharmacist can get a Master in Pharmaceutical Sciences (MSc), of 2 years, or a Doctorate in Pharmacology (PhD), of 4 years after finished the Bachelor, but these are Academic Degrees, needed for scientific career on investigation, but are not required to work in other professional areas.

Colombia[edit]

In Colombia, the title of Pharmacist (Quimico Farmaceutico) is granted after completing 10 semesters of full-time studies in an accredited University. The Pharmacist degree is a Professional Degree. While the term Pharm.D. is not formally regulated it can be used and is commonly added to the graduate's professional license (issued by the Colegio Nacional de Quimicos Farmaceuticos de Colombia).






Yes, individuals with a Doctor of Pharmacy (Pharm.D.) degree are entitled to use the "Dr." prefix, particularly in clinical and academic settings, as it is a professional doctorate. The Pharmacy Council of India (PCI) has explicitly authorized this for graduates, despite opposition from some medical associations.
Here are the key points regarding Pharm.D. and the "Dr." title:
  • Professional Recognition:
     The Pharm.D. is a 6-year professional doctorate degree (in India/abroad), making the usage of "Dr." formally appropriate for graduates.
  • Regulatory Backing: The Pharmacy Council of India (PCI) issued instructions to universities to use the "Dr." prefix for Pharm.D. graduates, affirming their doctoral status.
  • Scope & Context: While they are "Doctors of Pharmacy" or Clinical Pharmacists, they are distinct from medical practitioners (MBBS/MD) and are not authorized to practice medicine, perform surgery, or prescribe modern medicines beyond what is authorized for pharmacists.
  • Clinical Roles: They often work in hospitals, handling drug therapy monitoring, adverse effect reporting, and patient counseling.
Important Distinctions:
  • Pharmacists vs. Physicians: Using the title is meant to distinguish pharmacists with advanced clinical training (Pharm.D.) from those with undergraduate degrees (e.g., B.Pharm/D.Pharm).
  • Controversy: The Indian Medical Association (IMA) has formally opposed this in the past, arguing it may mislead patients, though regulatory bodies have upheld the right to use the title for Pharm.D. holders.
Note: In most countries, the legal authority to use the title "Dr." as a non-physician is widely accepted for those holding a professional doctoral degree, such as a Pharm.D.